60-year-old status post neoadjuvant therapy for triple negative breast cancer. Evaluate tumor response and axillary response. There is heterogeneous amount of fibroglandular tissue in both breasts.Mild parenchymal enhancement is noted bilaterally.There has been an overall interval decrease in the volume of abnormal right breast enhancement. However, a component of enhancement in the nipple and retroareolar region is increased/new. Currently, there is discontinuous non-mass enhancement extending from the nipple to the posterior depth of the right outer breast. Today this measures 8.0 x 2.2 x 7.0, previously 4.3 x 6.3 x 9.1 cm. A small focus is stable in the medial right breast. Right axillary lymphadenopathy is decreased, with the biopsied reference node measuring 1.1 cm, previously up to 1.7 cm. No suspicious enhancement is seen in the left breast. Stable left breast foci are noted superiorly. Lateral scarring from prior left lumpectomy is noted. No abnormal lymph nodes are identified in the left axillary region.A port-a-cath projects in the left upper chest wall.
Overall decrease in volume of abnormal right breast enhancement, though a component of enhancement near the nipple is increased on this exam. Decreased right axillary adenopathy. BIRADS: 6 - Known cancer.RECOMMENDATION: T - Take Appropriate Action - No Letter.